Prothena | PRTA - 市值



金融业
股票价格
USD
资产
USD 302.58M
现金及等价物
USD 288.19M
销售成本
USD 28.94M
流动资产
USD 292.01M
流动负债
USD 11.66M
债务
USD 7.65M
EBIT
USD 25.79M
EBITDA
USD 25.98M
员工
163
EPS每股收益
USD 0.6
股本和储备
USD 286.89M
销售毛利
USD 51.08M
债务利息支出
USD 302.58M
利息收入
USD 2.42M
贷款资金
USD 0
市值
USD 488.3M
净收入
USD 32.72M
营业费用
USD 25.29M
营业利润
USD 25.79M
普通股股本
USD 53.08M
PE价格收益
22.11
税前利润
USD 32.72M
销售收入
USD 51.08M
销售和管理费用
USD 12.67M
贸易债权人
USD 1.94M
应收帐款人
USD 5.16M


市值 更改 日
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 7.93B 806M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 209.65B 14.21B 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Exelixis USD 15.27B 1.73B 2026-08
Immunic USD 64M 23M 2025-12
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MacroGenics USD 184M 82M 2026-03
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Prothena USD 516M 2M 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08